Osteoporosis is widely regarded as one of the typical aging-related diseases due to the impairment of bone remodeling. The silent information regulator of transcription1 (SIRT1) is a vital regulator of cell survival and life-span. SIRT1 has been shown to be activated by resveratrol treatment, and also has been proved to prevent aging-related diseases such as osteoporosis. However, the role of SIRT1 about autophagy or mitophagy of osteoblasts in resveratrol-regulated osteoporotic rats remains unclear. This study seeks to investigate the role of SIRT1 about autophagy or mitophagy in osteoblasts through PI3K/Akt signaling pathway in resveratrol-regulated osteoporotic rats. The vivo experiment results have revealed that resveratrol treatment significantly improved bone quality and reduced the levels of serum alkaline phosphatase and osteocalcin in osteoporotic rats. Moreover, Western bolt analysis showed that expression of SIRT1, LC3, and Beclin-1 in osteoblasts increased, while p-AKT and p-mTOR were downregulated in osteoporosis rats with high dose resveratrol treatment. On the other hand, resveratrol treatment increased the SIRT1 activity, LC3 and Beclin-1 mRNA expression in the dexamethasone (DEX)-treated osteoblasts. More mitophagosomes were observed in the DEX-treated osteoblasts with resveratrol. Meanwhile, the TOM20, Hsp60, p-Akt and p-mTOR activities were decreased in the DEX-treated osteoblasts with resveratrol. Resveratrol treatment did not change the p-p38 and p-JNK activities in the osteoblasts. These results revealed that resveratrol treatment protected osteoblasts in osteoporosis rats by enhancing mitophagy by mediating SIRT1 and PI3K/AKT/mTOR signaling pathway.
Conflict of interest statement
The authors declare no competing interests.
Protective effects of resveratrol on postmenopausal osteoporosis: regulation of SIRT1-NF-κB signaling pathway.Acta Biochim Biophys Sin (Shanghai). 2014 Dec;46(12):1024-33. doi: 10.1093/abbs/gmu103. Epub 2014 Nov 6. Acta Biochim Biophys Sin (Shanghai). 2014. PMID: 25377437
Resveratrol, an activator of SIRT1, induces protective autophagy in non-small-cell lung cancer via inhibiting Akt/mTOR and activating p38-MAPK.Onco Targets Ther. 2018 Nov 2;11:7777-7786. doi: 10.2147/OTT.S159095. eCollection 2018. Onco Targets Ther. 2018. PMID: 30464525 Free PMC article.
Resveratrol protects against spinal cord injury by activating autophagy and inhibiting apoptosis mediated by the SIRT1/AMPK signaling pathway.Neuroscience. 2017 Apr 21;348:241-251. doi: 10.1016/j.neuroscience.2017.02.027. Epub 2017 Feb 24. Neuroscience. 2017. PMID: 28238848
Protective effects of resveratrol on osteoporosis via activation of the SIRT1-NF-κB signaling pathway in rats.Exp Ther Med. 2017 Nov;14(5):5032-5038. doi: 10.3892/etm.2017.5147. Epub 2017 Sep 20. Exp Ther Med. 2017. PMID: 29201210 Free PMC article.
Resveratrol protects early brain injury after subarachnoid hemorrhage by activating autophagy and inhibiting apoptosis mediated by the Akt/mTOR pathway.Neuroreport. 2018 Mar 21;29(5):368-379. doi: 10.1097/WNR.0000000000000975. Neuroreport. 2018. PMID: 29360689 Free PMC article.